Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Apixaban by Taho Pharmaceuticals for Pulmonary Embolism: Likelihood of Approval
Apixaban is under clinical development by Taho Pharmaceuticals and currently in Phase I for Pulmonary Embolism. According to GlobalData, Phase...
Apixaban by Taho Pharmaceuticals for Stroke: Likelihood of Approval
Apixaban is under clinical development by Taho Pharmaceuticals and currently in Phase I for Stroke. According to GlobalData, Phase I...
Apixaban by Taho Pharmaceuticals for Deep Vein Thrombosis (DVT): Likelihood of Approval
Apixaban is under clinical development by Taho Pharmaceuticals and currently in Phase I for Deep Vein Thrombosis (DVT). According to...
Apixaban by Bristol-Myers Squibb for Restenosis: Likelihood of Approval
Apixaban is under clinical development by Bristol-Myers Squibb and currently in Phase III for Restenosis. According to GlobalData, Phase III...